
Monday, January 31, 2022 10:38:44 AM
"As previously announced, Elusys has executed a definitive merger agreement with Heat Biologics, Inc. (NASDAQ: HTBX), pursuant to which Elusys will merge into a wholly owned subsidiary of Heat. The acquisition is expected to close during the first quarter of 2022 and is subject to customary closing conditions."

Liked By
Spread the love. Be the first to like this post!
FEATURED Nextech3D.ai Enters Asian Market with Major 3D Modeling Deal to Revolutionize E-Commerce • Mar 30, 2023 10:00 AM
ARway Secures Multiple New SDK Deals to Drive Growth in $44B Indoor Positioning and Navigation Market • ARWYF • Mar 30, 2023 10:30 AM
OMID Posts 2022 Annual Report and Provides Update • OMID • Mar 30, 2023 9:15 AM
ReoStar Energy Corporation Acquires Interest in Emerging Global Iron Ore Producer Leuffer Mining Group • REOS • Mar 30, 2023 9:05 AM
Chilco River Holdings Announces Acquisition of L. Myers Associates • CRVH • Mar 30, 2023 9:00 AM
Alliance Creative Group (ACGX) Reports Revenue of $3,399,008 for Fourth Quarter of 2022 • ACGX • Mar 30, 2023 8:30 AM